Placing Hong Kong on the World Liver Transplant Map: HKU’s Living Donor Liver Transplant Breakthroughs (from 1991)

The University of Hong Kong (HKU) Comprehensive Information Database · 04 Research Module Beyond its strengths in emerging infectious diseases/virology (see signature-virology-infection.md, hku-named-pathogens.md), another of HKU’s most internationally recognised research strengths is surgery—particularly living donor liver transplantation. This article focuses on this integrated clinical-research breakthrough. For an overview of research achievements, see achievements.md; for the teaching hospital Queen Mary Hospital, see ../11-medical-hospital/teaching-hospitals.md; for the State Key Laboratory of Liver Research (SKLLR), see institutes-and-labs.md. Historical and award-winning scientists are named according to this database’s conventions (00–12 Fact Zone) based on records; currently active clinical experts are reported only in relation to their professional contributions, without reference to other affiliations.

# 1. The Starting Point: Hong Kong’s First Liver Transplant in 1991

• According to the HKU Department of Surgery’s official page^※, the HKU team performed the first successful liver transplant in Hong Kong in October 1991;
• According to the same page^※, Queen Mary Hospital’s liver transplant service subsequently grew into one of the largest programmes of its kind in China and Southeast Asia.

# 2. The “Triple Jump” of Living Donor Liver Transplantation (1993 → 1996)

A shortage of donor livers is a global challenge for liver transplantation; living donor liver transplantation (where a healthy relative donates part of their liver) represents a key breakthrough approach. HKU advanced this approach step by step:

According to the HKU Dept. of Surgery official page^※, the 1996 adult right-lobe living donor liver transplant is described as an innovative technique that “provided a life-saving option for critically ill patients.”

# 3. Institutionalisation and Scale

• According to the HKU Dept. of Surgery official page^※, in November 2003, the unit was designated as the Liver Transplant Centre for Hong Kong; a newly established dedicated ward opened in October 2011.
• According to the same page (statistics as of early 2016)^※, a total of 1,148 transplants had been performed (134 paediatric, 1,014 adult); overall survival rates were 92.9% at 1 year, 88.2% at 3 years, and 85.8% at 5 years.

Context: A surgical technique that is a “world first,” combined with long-term, publicly available high survival rates, makes HKU’s liver transplantation a model of integrated clinical excellence and research output. Together with its strength in emerging infectious diseases, it shapes the dual profile of HKU medicine: treating the patient in front of you while pushing the frontiers of the discipline.

It is worth clarifying for readers that “surgical breakthroughs” and “laboratory breakthroughs” are often treated differently in research narratives—the former can be mistakenly seen as merely “doing a good operation” rather than a “scientific discovery.” Yet HKU’s living donor liver transplantation demonstrates that top-tier surgery is research in itself: from determining whether an adult can accept a living donor graft to whether to use the left or the right lobe, each step required systematic innovation in anatomy, physiology, and surgical technique, and was established in a way that is reproducible, publishable, and adoptable by others. The 1996 adult right-lobe living donor liver transplant is described as “rewriting global practice” precisely because it was not an isolated successful operation, but a method that could be learnt and replicated by transplant centres around the world—that is the true meaning of a “research breakthrough.” Its inclusion in the 04 Research Module (rather than being recorded merely as a clinical service) is precisely to emphasise that, beyond the frontline laboratory work on emerging infections, HKU medicine has another research axis, represented by “surgical innovation,” with equally world-class impact.

# 4. World-Class Recognition

• According to a SCMP report^※, the HKU/Queen Mary team performed what was described as a “world first” in complex liver transplantation, confirming the international cutting edge of their techniques.
• According to publicly available summaries, HKU’s pioneering work on adult right-lobe living donor liver transplantation has received recognition through China’s national-level science and technology awards (exact award names and years are subject to official announcements; this article refrains from pinning down a single detail to avoid inaccuracy).

# 5. Unconfirmed / Pending Verification

• 2005 State Science and Technology Progress Award: Anecdotal and media reports mention a “First Prize of the State Science and Technology Progress Award in 2005”; however, the HKU Dept. of Surgery’s official page does not list this award. This article, based on the official page, records the technical milestones and only makes the cautious statement “has received recognition through national-level awards”; the exact award details are subject to official announcements.
• Year-by-year and latest cumulative case numbers: This article relies on the “as of early 2016” statistics on the official page; for the most recent cumulative numbers, the latest publications from HKU Dept. of Surgery and Queen Mary Hospital should be consulted.
• Naming of team members: In line with the Fact Zone conventions, this article focuses on institutional and technical milestones; the names of lead surgeons and team members are to be confirmed from official publications and paper authorship.